ArticleThe Journal of clinical investigation2011

Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer.

Navjotsingh Pabla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.